An overview of the initial experience with AK-2123 as a hypoxic cell sensitizer with radiation in the treatment of advanced head and neck cancers.

Source:http://linkedlifedata.com/resource/pubmed/id/8600096

Int. J. Radiat. Oncol. Biol. Phys. 1996 Mar 15 34 5 1121-4

Download in:

View as

General Info

PMID
8600096